VFA
GMAB icon

Valeo Financial Advisors’s Genmab GMAB Stock Holding History

Valeo Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-47
Closed -$2K – 1800
2020
Q2 		$2K Sell
47
-30
-39% -$818 ﹤0.01% 1755
2020
Q1 		$2K Buy
77
+25
+48% +$557 ﹤0.01% 1528
2019
Q4 		$1K Buy
+52
New +$1.14K ﹤0.01% 1535

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Valeo Financial Advisors's GMAB Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Genmab (GMAB) in Q3 2020, closing a stake of 47 shares — an estimated $2K sold.

Valeo Financial Advisors first reported a position in GMAB in Q4 2019 and held it in 3 quarters. The position peaked at $2K in Q2 2020. 198 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Genmab position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 47 Genmab shares in Q3 2020, an estimated $2K.
  • Valeo Financial Advisors first reported a position in Genmab in Q4 2019 and held it in 3 quarters.
  • Valeo Financial Advisors's Genmab position peaked at $2K in Q2 2020.
  • 198 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.